Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
life sciences
national blog main
roche
7
×
san diego blog main
san diego top stories
startups
7
×
boston blog main
boston top stories
detroit blog main
detroit top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boulder/denver blog main
boulder/denver top stories
cancer
indiana blog main
indiana top stories
national
biogen
cancer immunotherapy
fda
investing
alzheimer's disease
clinical trials
cystic fibrosis
drug prices
pfizer
What
roundup
bio
companies
drug
ahead
asco
crispr
days
life
sciences
today
acquisitions
admits
ago
albert
alliance
alzheimer’s
ambien
american
annual
attendees
attention
awards
big
biggest
biotech
biotechs
bourla
branded
bristol
buy
calls
camp’s
cancer
cash
ceo
changing
chicago
choices
city
Language
unset
unknown
Current search:
roche
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Meet the Xconomy Awards San Diego Digital Trailblazer Finalists
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More